ANI Pharmaceuticals hydroxyzine recalled for foreign substance
ANI Pharmaceuticals is recalling hydroxyzine hydrochloride oral solution (10 mg/5 mL, 473 mL bottles) due to the presence of a foreign substance in one lot. The affected product was distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have hydroxyzine oral solution lot S25133A (NDC 70954-912-10).
- Stop using the product and contact your pharmacy or healthcare provider.
- Do not flush or throw away the medication; ask your pharmacist how to safely dispose of it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 6564 bottles
- Illnesses reported
- None reported
- Manufactured in
- 210 W Main St, N/A, Baudette, MN, United States
- Classification
- Class III
- Recall number
- D-0619-2026
In the FDA's words
- Description
- hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10 Presence of foreign substance Lot S25133A Distribution: Nationwide in the USA Affected quantity: 6564 bottles
- Hazard
- Presence of foreign substance